EH

Eddie Hickman

#373 out of 1697 analysts
Guggenheim
Automatically Tracked
Tracking: 0 Updated: 7 hours ago

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
23.39%
Gain -2.97%
Monthly
0.84%
Yearly
10.56%
Drawdown
60.35%
$142,645.38
Equity
Holdings
$142,645.38
Cash
$0
Investment
$188,661.28
$42,645.38
Profit -$4,370.69
Realized
$88,661.28
Unrealized
-$46,015.9
Dividends
$0
$0
Cash
Deposits
$100,000
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
-2.97%
Profit
-$4,370.69
Win %
0%
This Week
Compared To Last Week
Gain
-12.96%
Profit
-$21,239.26
Win %
0%
This Month
Compared to last month
Gain
-15.31%
Profit
-$25,776.52
Win %
0%
This Year
Compared to last year
Gain
23.42%
Profit
$27,069.17
Win %
54%
No Data
Zevra Therapeutics, Inc. logo
ZVRA Zevra Therapeutics, Inc.
-3.31%
-$2,774.43
GH Research plc logo
GHRS GH Research plc
-2.52%
-$1,596.26
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
53
Longs Won
26/53 49%
Profit Factor
1.29
Profitability
Shorts Won
0/0 0%
Standard Deviation
$10,086.64
Average Win
$7,211.04
Best Trade
(Jul 12) $31,308.41
Sharpe Ratio
-18.21
Average Loss
-$5,364.51
Worst Trade
(Oct 16) -$32,714.95
Z-Score
-1.66 (91.36%)
Commissions
$0
Avg. Trade Length
2m 1w 2d
Expectancy
$804.63
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% 0.67% 3.02% 7.28% 13.62% 22.13% 32.91% 46.02% 61.54% 79.51%
Consecutive Losing Trades 27 24 21 19 16 13 11 8 5 3
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
Symbol Quantity Cost Value Comm. Profit (&#36;) Gain (%) Change
GH Research plc logo
GHRS GH Research plc
3,360.55 $94,330.64 $61,615.68 - -$32,714.96 -34.68%
-2.525%
Zevra Therapeutics, Inc. logo
ZVRA Zevra Therapeutics, Inc.
8,160.09 $94,330.64 $81,029.69 - -$13,300.95 -14.1%
-3.311%
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV